Search by Drug Name or NDC
NDC 43063-0996-02 Triazolam 0.25 mg/1 Details
Triazolam 0.25 mg/1
Triazolam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is TRIAZOLAM.
MedlinePlus Drug Summary
Triazolam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Triazolam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.
Related Packages: 43063-0996-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Triazolam
Product Information
NDC | 43063-0996 |
---|---|
Product ID | 43063-996_007700af-ce41-081a-e063-6294a90a0d75 |
Associated GPIs | 60201040000310 |
GCN Sequence Number | 003694 |
GCN Sequence Number Description | triazolam TABLET 0.25 MG ORAL |
HIC3 | H21 |
HIC3 Description | SEDATIVE-HYPNOTICS - BENZODIAZEPINES |
GCN | 14280 |
HICL Sequence Number | 001594 |
HICL Sequence Number Description | TRIAZOLAM |
Brand/Generic | Generic |
Proprietary Name | Triazolam |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Triazolam |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 0.25 |
Active Ingredient Units | mg/1 |
Substance Name | TRIAZOLAM |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
DEA Schedule | CIV |
Marketing Category | ANDA |
Application Number | ANDA074224 |
Listing Certified Through | 2024-12-31 |
Package
NDC 43063-0996-02 (43063099602)
NDC Package Code | 43063-996-02 |
---|---|
Billing NDC | 43063099602 |
Package | 2 TABLET in 1 BOTTLE, PLASTIC (43063-996-02) |
Marketing Start Date | 2019-12-17 |
NDC Exclude Flag | N |
Pricing Information | N/A |